Authorized Generics Explained

A Brave (Expensive) New World for Payers

One of Big Pharma’s Bad Actors Goes Bust

The Latest on Drug Patent Scams

How Are Drug Rebates Still a Thing?

Generic Drugmakers Are in Big Trouble